Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-12-08FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for irbesartan from NorthStar RxLLC, authorizing changes to an existing generic product under an…
-
FDA approval · 2021-12-08FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for Irbesartan and Hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc. to support the comme…
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure [Phase 4]
Clinical trial comparing spironolactone and indapamide, alone or with amlodipine, for reducing heart failure risk in hypertension (Phase 4).
-
CLINICAL_TRIALS trial_result · 2021-12-07Clinical Trial Update: Moxonidine Effects on Neuropeptide Y [Phase 4]
Phase 4 trial updating the effects of moxonidine on neuropeptide Y in obesity and hypertension, completed.
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for valsartan submitted by Aurobindo Pharma Limited, updating the existing approval for this generic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-12-06FDA Approved: VALSARTAN — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for VALSARTAN from Macleods Pharmaceuticals Limited. This approval supports continued distribution o…
-
FDA approval · 2021-12-03FDA Approved: IRBESARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for irbesartan submitted by Lupin Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Mechanisms of Refractory Hypertension (Reserpine) [Phase 2]
Phase 2 clinical trial update for reserpine in refractory hypertension has completed with posted results.
-
FDA approval · 2021-11-19FDA Approved: NEBIVOLOL — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for Nebivolol from Ascend Laboratories, LLC (ANDA 203828).
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension [Phase 3]
Phase 3 trial update on renal denervation using ultrasound for 24-hour blood pressure control in resistant hypertension has completed.
-
FDA approval · 2021-11-09FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Procardia XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc, updating the drug's label…
-
FDA approval · 2021-11-08FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for a generic metoprolol succinate product from Epic Pharma, LLC.
-
FDA approval · 2021-11-04FDA Approved: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' generic fixed-dose combination tablet of bisoprolol fumarate and hydrochlorothiazide for hypertension.
-
FDA approval · 2021-11-02FDA Approved: VALSARTAN — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for valsartan, enabling generic manufacture and marketing of valsartan for its approved …
-
FDA approval · 2021-10-27FDA Approved: VALSARTAN — Original Application (ScieGen Pharmaceuticals, INC.)
FDA approves the original application for VALSARTAN (Valsartan) from ScieGen Pharmaceuticals as a generic angiotensin II receptor blocker. I…
-
EMA approval · 2021-10-26EMA Authorised: Telmisartan Teva Pharma (telmisartan) — Teva B.V.
The EMA authorised Telmisartan Teva Pharma (telmisartan) for hypertension, with Teva B.V. as the marketing authorization holder.
-
FDA approval · 2021-10-25FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira's supplemental application for metoprolol tartrate (generic beta-blocker), under an ANDA.
-
FDA approval · 2021-10-25FDA Approved: EPLERENONE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approves Westminster Pharmaceuticals' original ANDA for EPLERENONE (generic eplerenone), providing a generic option for hypertension and…
-
FDA approval · 2021-10-25FDA Approved: ATENOLOL AND CHLORTHALIDONE — Original Application (MARLEX PHARMACEUTICALS, INC)
FDA approved Atenolol and Chlorthalidone tablets as an Original Application under an ANDA from Marlex Pharmaceuticals, for the treatment of …
-
FDA approval · 2021-10-15FDA Approved: TELMISARTAN — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved a supplemental application for telmisartan from Glenmark Pharmaceuticals Inc., USA, resulting in updated labeling for the d…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III [NA]
Completed clinical trial evaluating the effect of a NSS to reduce complications in patients with COVID-19 and comorbidities; results posted …
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED) [Phase 3]
Phase 3 trial update for ENCHANTED evaluating enhanced blood pressure control and thrombolysis in ischemic stroke patients.
-
CLINICAL_TRIALS trial_result · 2021-10-11Clinical Trial Update: A Dose Finding Study Of PF-00489791 In Patients With Mild To Moderate High Blood Pressure [Phase 2]
Phase 2 dose-finding trial of PF-00489791 in adults with mild to moderate hypertension has completed; results posted.
-
FDA approval · 2021-10-05FDA Approved: VALSARTAN — Original Application (Dr. Reddy's Laboratories Limited)
FDA approves the original application for valsartan from Dr. Reddy's Laboratories Limited, granting approval for the generic product.
-
FDA approval · 2021-10-01FDA Approved: RAMIPRIL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Ramipril from Rising Pharma Holdings, Inc., enabling the continued manufacture and distribut…